Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$210K Buy
2,204
+883
+67% +$84.8K ﹤0.01% 774
2026
Q1
$137K Sell
1,321
-4
-0.3% -$453 ﹤0.01% 894
2025
Q4
$134K Sell
1,325
-8
-0.6% -$869 ﹤0.01% 934
2025
Q3
$164K Buy
1,333
+104
+8% +$12.9K ﹤0.01% 872
2025
Q2
$148K Sell
1,229
-20
-2% -$2.67K ﹤0.01% 882
2025
Q1
$184K Hold
1,249
﹤0.01% 748
2024
Q4
$203K Buy
1,249
+336
+37% +$55K ﹤0.01% 653
2024
Q3
$125K Buy
913
+235
+35% +$34.8K ﹤0.01% 1099
2024
Q2
$104K Buy
678
+85
+14% +$11.8K ﹤0.01% 958
2024
Q1
$90.8K Sell
593
-105
-15% -$15.7K ﹤0.01% 741
2023
Q4
$91K Buy
698
+77
+12% +$10.3K ﹤0.01% 711
2023
Q3
$99K Sell
621
-11
-2% -$1.67K ﹤0.01% 620
2023
Q2
$100K Sell
632
-20
-3% -$3.23K ﹤0.01% 503
2023
Q1
$92K Buy
652
+587
+903% +$88K ﹤0.01% 798
2022
Q4
$8K Buy
65
+29
+81% +$4.12K ﹤0.01% 1583
2022
Q3
$5K Sell
36
-23
-39% -$3.32K ﹤0.01% 1557
2022
Q2
$8K Buy
+59
New +$8.43K ﹤0.01% 1267

Other funds holding CLX

Blue Trust Inc's CLX Position: Q2 2026 in Review

Blue Trust Inc increased its Clorox (CLX) stake by 67% in Q2 2026, buying an estimated $84.8K and bringing the position to 2,204 shares worth $210K. The position accounts for ﹤0.01% of the portfolio, ranked #774.

Blue Trust Inc first reported a position in CLX in Q2 2022 and has held it in 17 quarters since. 1,041 funds tracked by Wall St. Rank hold CLX as of Q2 2026.

  • Blue Trust Inc held 2,204 shares of Clorox worth $210K as of Q2 2026.
  • Blue Trust Inc bought 883 Clorox shares in Q2 2026, an estimated $84.8K.
  • Clorox made up ﹤0.01% of Blue Trust Inc's portfolio in Q2 2026, its #774 holding.
  • Blue Trust Inc first reported a position in Clorox in Q2 2022 and has held it in 17 quarters since.
  • 1,041 funds tracked by Wall St. Rank held Clorox as of Q2 2026.

Based on Blue Trust Inc's 13F filing for Q2 2026, filed 21 Jul 2026.